Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and...
PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and...
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that...
The first investigational FcRn blocker to demonstrate sustained disease control over 24 weeks in antibody positive adult patients: anti-AChR+, anti-MuSK+,...
Tokyo, Japan and Cambridge, UK, 23 January 2025 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565) will announce its earnings...
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
CHAPEL HILL, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a...
--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people...
Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry...
SARASOTA, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for...
MADRID, Spain and CAMBRIDGE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...
More than 80% of Physicians Observe Sex Differences in Disease Progression and Treatment Response, Yet Less than 30% Feel Equipped...
LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business,...
Denver Health clinicians reported a 40% reduction in note-typing per patient encounter during an eight-week pilot programNabla's advanced ambient AI...
DELRAY BEACH, Fla., Jan. 15, 2025 /PRNewswire/ -- The global AI medical imaging market, valued at US$ 1.29 billion in 2023,...
PHYRAGO™ Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI,...
Complex veterinary procedure restores health and qualify of life, offering new hope to pet-parents facing complicated neurological disorders BEND, OREGON...
Century Health's AI platform integrates with EHRs to unlock valuable clinical data that has been historically messy, unstructured and inaccessibleNira...
Century Health's AI platform integrates with EHRs to unlock valuable clinical data that has been historically messy, unstructured and inaccessibleNira...
NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Tennis Social AI proudly announces Brian Hainline, MD as its Chief Innovation and...
NEW YORK, Jan. 14, 2025 /PRNewswire/ -- Tennis Social AI proudly announces Brian Hainline, MD as its Chief Innovation and...